Small Business Resources, Business Advice and Forms from AllBusiness.com

Taro Reports ``A'' Bond Rating in Israel.

HAWTHORNE, N.Y. -- Taro Pharmaceutical Industries Ltd. ("Taro," "the Company," NASDAQ: TARO) today reported that it has received an "A" rating from Maalot, the Israeli affiliate of Standard & Poor's, based on the rating standard employed in Israel, for the

debt securities previously issued by the Company in Israel. The prior Maalot rating of the debt securities was "A+."

The new "A" rating does not affect the terms of bonds previously issued by Taro.

Taro is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

For further information on Taro, please visit the Company's website at www.taro.com.

In addition, make sure to read these articles: